Tuesday 05 October 2019 - Healthy Nation
Bedaquiline is one of the only three effective TB drugs to be developed in over 50 years.
Médecins Sans Frontières/Doctors Without Borders (MSF) said lowering the price of bedaquiline will enable a scale-up of drug-resistant treatment and reduction of deaths.
Currently, J & J charges double the price that MSF is asking — about $400 for a six-month treatment course for countries eligible to buy the drug through the Global Drug Facility (GDF).